GLP-1 therapies gain popularity, but patient adherence struggles due to fragmented support and emotional barriers.
Mark Gregory, RPh
Advertisement
Articles by Mark Gregory, RPh
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Maternal Health Awareness Day: Advocacy, Policy Crucial for Protecting Access to Maternal Health
2
More Than 200 Organizations Denounce Childhood Vaccine Schedule Change
3
IRA Drug Price Negotiations Threatening Pharmacies’ Financial Sustainability
4
Congressional Spending Bill to Include Key PBM Contracting Reform
5